Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial cystitis antiproliferative factor (APF) as a cell-cycle modulator.

Hani H Rashid1, Jay E Reeder, Mary J O'Connell

  • 1Department of Urology, University of Rochester, Rochester, New York, USA. hani_rashid@urmc.rochester.edu

BMC Urology
|April 8, 2004
PubMed
Summary

Antiproliferative factor (APF) disrupts normal bladder cell cycles, increasing polyploidy. This peptide may contribute to interstitial cystitis (IC) by hindering urothelial repair and proliferation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Through the Eyes of the Applicant: A Qualitative Study of the Urology Residency Match.

Urology·2026
Same author

A risk-adapted approach to reTURBT in high-grade T1 NMIBC.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

Circulating tumor DNA-guided adjuvant immunotherapy in muscle-invasive bladder cancer.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

InspectorORF: a tool for visualizing Ribo-Seq and additional genomic or transcriptomic data.

Bioinformatics advances·2026
Same author

Neoadjuvant chemotherapy for high-risk upper tract urothelial cancer.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

The complete genome of a songbird.

bioRxiv : the preprint server for biology·2026

Area of Science:

  • Urology
  • Cell Biology
  • Pathophysiology

Background:

  • Interstitial cystitis (IC) is a chronic bladder condition with unknown causes.
  • Antiproliferative factor (APF), a urinary peptide in IC patients, inhibits normal bladder epithelial cell proliferation.
  • APF's antiproliferative mechanism requires further investigation.

Purpose of the Study:

  • To investigate the specific effects of APF on the cell cycle of normal bladder epithelial cells.
  • To elucidate the antiproliferative activity of APF in the context of urothelial cells.

Main Methods:

  • Bladder epithelial cells from normal biopsy specimens were cultured.
  • Cells were exposed to APF or a mock control.
  • DNA cytometry and automated image analysis were used to assess cell cycle phase fractions.

Related Experiment Videos

Main Results:

  • APF exposure led to significant increases in tetraploid and hypertetraploid cells.
  • These findings suggest a G2 and/or M phase cell cycle block.
  • The study observed the production of polyploidy in response to APF.

Conclusions:

  • APF demonstrates a specific impact on cell cycle distribution.
  • The antiproliferative activity of APF may play a role in interstitial cystitis pathogenesis.
  • APF could disrupt normal urothelial proliferation and repair processes in IC.